PD-0325901 

To Order Contact us: stephen@expresspharmapulse.com

PD-1/PD-L1 Inhibitor 1

B1213-25
EUR 566

PD-1/PD-L1 Inhibitor 1

B1213-5
EUR 185

PD 407824

HY-18961 100mg
EUR 1542

PD 151746

HY-19749 50mg
EUR 491

PD 169316

HY-10578 10mM/1mL
EUR 255

PD 90780

HY-110166 5mg
EUR 326

PD 117519

HY-100032 5mg
EUR 119

PD-166866

HY-101296 10mM/1mL
EUR 138

PD-159020

HY-101598 1mg
EUR 1125

PD 123319

HY-10259 5mg
EUR 182

PD 0332991

E1KS1116 5mg
EUR 677

PD-ECGF

PR15044 10 ug
EUR 487

PD 98,059

GK2140-10MG 10 mg
EUR 172

PD 98,059

GK2140-1MG 1 mg
EUR 91

PD 98,059

GK2140-50MG 50 mg
EUR 378

PD 98,059

GK2140-5MG 5 mg
EUR 137

PD 150,606

GL2543-25MG 25 mg
EUR 413

PD 150,606

GL2543-5MG 5 mg
EUR 154

PD-ECGF

GT15181 100 ug
EUR 526

PD 166326

C3677-1 1 mg
EUR 161
Description: IC50: 8 nM for c-abl PD 166326 is a receptor tyrosine kinase inhibitor.Receptor tyrosine kinases are the high-affinity cell surface receptors for many growth factors, cytokines, as well as hormones.

PD 166326

C3677-10 10 mg
EUR 940
Description: IC50: 8 nM for c-abl PD 166326 is a receptor tyrosine kinase inhibitor.Receptor tyrosine kinases are the high-affinity cell surface receptors for many growth factors, cytokines, as well as hormones.

PD 166326

C3677-5 5 mg
EUR 551
Description: IC50: 8 nM for c-abl PD 166326 is a receptor tyrosine kinase inhibitor.Receptor tyrosine kinases are the high-affinity cell surface receptors for many growth factors, cytokines, as well as hormones.

PD 81723

B6705-10 10 mg
EUR 284

PD 81723

B6705-50 50 mg
EUR 1038

PD 102807

B6821-10 10 mg
EUR 389

PD 102807

B6821-50 50 mg
EUR 1476

PD 160170

B6972-10 10 mg
EUR 340

PD 176252

B7122-10 10 mg
EUR 512

PD 198306

B7124-1 1 mg
EUR 126
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK).

PD 198306

B7124-10 10 mg
EUR 529
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK).

PD 198306

B7124-5 5 mg
EUR 318
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK).

PD 135158

B7127-10 10 mg
EUR 486

PD 135158

B7127-50 50 mg
EUR 1850

PD 184161

C4361-10 10 mg
EUR 283
Description: IC50: 10-100 nMPD 184161 is a MEK1/2 inhibitor. The intracellular signaling pathway of mitogen-activated protein kinases is involved in the regulation of various cellular functions.

PD 184161

C4361-25 25 mg
EUR 561
Description: IC50: 10-100 nMPD 184161 is a MEK1/2 inhibitor. The intracellular signaling pathway of mitogen-activated protein kinases is involved in the regulation of various cellular functions.

PD 184161

C4361-5 5 mg
EUR 181
Description: IC50: 10-100 nMPD 184161 is a MEK1/2 inhibitor. The intracellular signaling pathway of mitogen-activated protein kinases is involved in the regulation of various cellular functions.

PD 151746

B4791-100 100 mg
EUR 595
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms.

PD 151746

B4791-25 25 mg
EUR 282
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms.

PD 151746

B4791-5 5 mg
EUR 119
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms.

PD 151746

B4791-5.1 10 mM (in 1mL DMSO)
EUR 126
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms.

PD 334581

B5727-10 10 mg
EUR 486

PD 334581

B5727-50 50 mg
EUR 1850

PD 150606

A4413-25 25 mg
EUR 428
Description: PD 150606 is a specific inhibitor of calpain with Ki value of 0.21 ?M and 0.37 ?M for mu- and m- calpains, respectively [1].

PD 150606

A4413-5 5 mg
EUR 144
Description: PD 150606 is a specific inhibitor of calpain with Ki value of 0.21 ?M and 0.37 ?M for mu- and m- calpains, respectively [1].

PD 166793

A4438-10 10 mg
EUR 242
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure.

PD 166793

A4438-25 25 mg
EUR 498
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure.

PD 166793

A4438-5 5 mg
EUR 187
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure.

PD 173074

A8253-10 10 mg
EUR 108
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells.

PD 173074

A8253-5.1 10 mM (in 1mL DMSO)
EUR 119
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells.

PD 173074

A8253-50 50 mg
EUR 212
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells.

PD 173074

A8253-S Evaluation Sample
EUR 81
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells.

PD 180970

A8606-10 10 mg
EUR 431
Description: ATP-competitive inhibitor of p210bcr/abl tyrosine kinase; selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells. Inhibits in vivo tyrosine phosphorylation of Gab2, CrkL and p210bcr/abl (IC50 values are 80, 80 and 170 nM respectively).

PD 145305

C5830-10 10 mg
EUR 428
Description: PD 145305 is an inactive analog of PD 150606, a potent and selective calpains inhibitor [1]. Calpain is a class of cytosolic cysteine protease that is activated by elevated intracellular calcium.

PD 145305

C5830-5 5 mg
EUR 263
Description: PD 145305 is an inactive analog of PD 150606, a potent and selective calpains inhibitor [1]. Calpain is a class of cytosolic cysteine protease that is activated by elevated intracellular calcium.

PD 169316

A8689-10 10 mg
EUR 163
Description: IC50: A potent, selective and cell-permeable suppressor of p38 MAP kinase, with the IC50 value of 89 nM.PD169316, a specific p38 MAPK inhibitor, blocks signal transduction mediated by both TGF-? and Activin A, but not bone morphogenetic protein (BMP) 4.

PD 169316

A8689-5.1 10 mM (in 1mL DMSO)
EUR 224
Description: IC50: A potent, selective and cell-permeable suppressor of p38 MAP kinase, with the IC50 value of 89 nM.PD169316, a specific p38 MAPK inhibitor, blocks signal transduction mediated by both TGF-? and Activin A, but not bone morphogenetic protein (BMP) 4.

PD 169316

A8689-50 50 mg
EUR 496
Description: IC50: A potent, selective and cell-permeable suppressor of p38 MAP kinase, with the IC50 value of 89 nM.PD169316, a specific p38 MAPK inhibitor, blocks signal transduction mediated by both TGF-? and Activin A, but not bone morphogenetic protein (BMP) 4.

PD 158780

B7130-10 10 mg
EUR 232

PD 158780

B7130-25 25 mg
EUR 453

PD 158780

B7130-5 5 mg
EUR 151

PD 118057

B7203-10 10 mg
EUR 334

PD 118057

B7203-50 50 mg
EUR 1243

PD 146176

B7208-10 10 mg
EUR 150

PD 146176

B7208-25 25 mg
EUR 287

PD 146176

B7208-50 50 mg
EUR 473

PD 173212

B7424-10 10 mg
EUR 529

PD 173212

B7424-5 5 mg
EUR 376

PD 173212

B7424-5.1 10 mM (in 1mL DMSO)
EUR 479

PD 161570

B7486-10 10 mg
EUR 454

PD 161570

B7486-50 50 mg
EUR 1714

PD 169316

B1703-25
EUR 544

PD 169316

B1703-5
EUR 175

PD-166866

B2223-25
EUR 675

PD-166866

B2223-5
EUR 207

PD-146176

B2313-25
EUR 675

PD-146176

B2313-5
EUR 207

PD-168393

B2352-25
EUR 414

PD-168393

B2352-5
EUR 142

PD 98059

1666-5
EUR 158

PD 173074

1675-1
EUR 137

PD 173074

1675-100 Ask for price

PD 150,606

1906-25
EUR 370

PD 150,606

1906-5
EUR 137

Ribosome-inactivating protein PD-L1/PD-L2 Antibody

1-CSB-PA306294LA01PJJ
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Unconjugated. Tested in the following application: ELISA

Ribosome-inactivating protein PD-L1 / PD-L2 Antibody

20-abx319445
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

PD-168077 maleate

HY-21098A 10mM/1mL
EUR 176

(+)-PD 128907 hydrochloride

HY-110000 50mg
EUR 751

PD 123319 (ditrifluoroacetate)

HY-10259A 10mg
EUR 215

PD-1,CD279

E6TA00107 0.1mg
EUR 343

PD-L1, CD274

E6TA00108 0.1mg
EUR 343

PD 98059, >99%

BC064-010 10mg
EUR 232

PD 98059, >99%

BC064-025 25mg
EUR 300

PD 98059, >99%

BC064-050 50mg
EUR 448

PD-1 Antibody

24505-100ul 100ul
EUR 390

PD-1 Antibody

24506-100ul 100ul
EUR 390

PD-L1 Protein

20-abx261703
  • EUR 3418.00
  • EUR 328.00
  • EUR 230.00
  • 1 mg
  • 20 ug
  • 5 ug

PD-L1 Protein

20-abx263458
  • EUR 1609.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 10 ug
  • 2 µg

PD-ECGF Antibody

abx236264-100ug 100 ug
EUR 551

PD 168077 maleate

B6578-10 10 mg
EUR 302

PD 168077 maleate

B6578-50 50 mg
EUR 1096

PD 144418 oxalate

B7125-10 10 mg
EUR 340

PD 144418 oxalate

B7125-50 50 mg
EUR 1276

PD-L1 Antibody

49251-100ul 100ul
EUR 333

PD-L1 Antibody

49251-50ul 50ul
EUR 239

PD-1 Antibody

P1001-01m 0.1m
EUR 165

PD-1 Antibody

P1001-1ml 1ml
EUR 376

PD-L1 Antibody

P1013-01m 0.1m
EUR 187

PD-L1 Antibody

P1013-1ml 1ml
EUR 673

PD 168568 dihydrochloride

B7420-10 10 mg
EUR 308

PD 168568 dihydrochloride

B7420-50 50 mg
EUR 1136

PD 0332991 (Palbociclib)

B7798-25 25 mg
EUR 154
Description: PD-0332991 is selective and oral inhibitor of cyclin-dependent kinase 4/6 with IC50 values of 11nM and 16nM, respectively for CDK4 and CDK6 [1].PD-0332991 is a highly specific inhibitor of CDK4/6.

PD 0332991 (Palbociclib)

B7798-5 5 mg
EUR 108
Description: PD-0332991 is selective and oral inhibitor of cyclin-dependent kinase 4/6 with IC50 values of 11nM and 16nM, respectively for CDK4 and CDK6 [1].PD-0332991 is a highly specific inhibitor of CDK4/6.

PD 0332991 (Palbociclib)

B7798-S Evaluation Sample
EUR 81
Description: PD-0332991 is selective and oral inhibitor of cyclin-dependent kinase 4/6 with IC50 values of 11nM and 16nM, respectively for CDK4 and CDK6 [1].PD-0332991 is a highly specific inhibitor of CDK4/6.

PD 123319 ditrifluoroacetate

A3704-10 10 mg
EUR 209
Description: Description:IC50 Value: 1.2 ±0.4 mM (Inhibition of adenylyl cyclase elicited by 0.1 microM Ang II) [2]PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist.

PD 123319 ditrifluoroacetate

A3704-25 25 mg
EUR 408
Description: Description:IC50 Value: 1.2 ±0.4 mM (Inhibition of adenylyl cyclase elicited by 0.1 microM Ang II) [2]PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist.

PD 123319 ditrifluoroacetate

A3704-5 5 mg
EUR 171
Description: Description:IC50 Value: 1.2 ±0.4 mM (Inhibition of adenylyl cyclase elicited by 0.1 microM Ang II) [2]PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist.

PD 123319 ditrifluoroacetate

A3704-50 50 mg
EUR 656
Description: Description:IC50 Value: 1.2 ±0.4 mM (Inhibition of adenylyl cyclase elicited by 0.1 microM Ang II) [2]PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist.

Anti-PD-L1

DB241-RTU-15 15 ml
EUR 678
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

Anti-PD-L1

DB241-RTU-7 7 ml
EUR 433
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

Anti-PD-L1

DB-241-0.1 100 μl
EUR 391
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Anti-PD-L1

DB-241-0.2 200 μl
EUR 563
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Anti-PD-L1

DB-241-0.5 500 μl
EUR 741
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Anti-PD-L1

DB-241-1 1 ml
EUR 1209
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Anti-PD-L1

DB-241-RTU-15 15 ml
EUR 678
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

Anti-PD-L1

DB-241-RTU-7 7 ml
EUR 433
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

PD-L1 Antibody

4059-002mg 0.02 mg
EUR 171.82
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4).

PD-L1 Antibody

4059-01mg 0.1 mg
EUR 436.42
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4).

PD-L2 Antibody

4063-002mg 0.02 mg
EUR 171.82
Description: PD-L2 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by co gnate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2, both of which are thought act as a negative regulator of T cell activation. However, it has been suggested that PD-L2 can act to stimulate an immunogenic response through and alternative receptor from PD-1.

PD-L2 Antibody

4063-01mg 0.1 mg
EUR 436.42
Description: PD-L2 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by co gnate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2, both of which are thought act as a negative regulator of T cell activation. However, it has been suggested that PD-L2 can act to stimulate an immunogenic response through and alternative receptor from PD-1.

PD-1 Antibody

4065-002mg 0.02 mg
EUR 171.82
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases.

PD-1 Antibody

4065-01mg 0.1 mg
EUR 436.42
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases.

PD-1 Antibody

4067-002mg 0.02 mg
EUR 171.82
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases.

PD-1 Antibody

4067-01mg 0.1 mg
EUR 436.42
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases.

PD-L1 Peptide

46-156P 0.1 mg
EUR 338
Description: CD274 / PD-L1 Peptide

PD-L1 Peptide

4059P 0.05 mg
EUR 164.75
Description: (IN) PD-L1 peptide

PD-L2 Peptide

4063P 0.05 mg
EUR 164.75
Description: (IN) PD-L2 peptide

PD-1 Peptide

4065P 0.05 mg
EUR 164.75
Description: (CT) PD-1 peptide

PD-1 Peptide

4067P 0.05 mg
EUR 164.75
Description: (IN) PD-1 peptide

PD-166285 dihydrochloride

B2094-25
EUR 631

PD-166285 dihydrochloride

B2094-5
EUR 196

PD-0332991 isethionate

9480-25
EUR 544

PD-0332991 isethionate

9480-5
EUR 175

PD-123319 ditrifluoroacetate

9640-25
EUR 631

PD-123319 ditrifluoroacetate

9640-5
EUR 196

PD 153035 Hydrochloride

1656-2
EUR 158

EZSolution? PD 98059

1783-5
EUR 158

Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2

1-CSB-EP306294PJJ
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2 expressed in E.coli

Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (HRP)

20-abx319446
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (FITC)

20-abx319447
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

PD-0325901